Cormorant Private Healthcare Fund II, LP

CIK 1747677 · last filed 2023-06-26

Cormorant Private Healthcare Fund II, LP is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for ERAS, was dated Jun 26, 2023. Across all open-market trades the lifetime net is +$65.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $269.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$269.06M

Companies

2

Total Filings

3

Lifetime Open-Market Net

$65.00M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ERAS	Director	10,813,246	$19.34	$209.13M	$8.00M	2	2023-06-26
GLUE	10%+ Owner	2,602,200	$23.03	$59.93M	$57.00M	1	2021-06-30

Recent Filings

3 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-06-26	ERAS	Grant (A)	—	$0	EDGAR
2022-12-20	ERAS	Buy (P)	+1,230,768	$8.00M	EDGAR
2021-06-30	GLUE	Mixed	+16,011,000	$57.00M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.